Retail Rx Fights Medicaid Final Rule

WASHINGTON Retail pharmacy associations spoke out last week opposing the Medicaid generic drug reimbursement formula, released on July 6 by the Centers for Medicare & Medicaid Services, Baltimore. The new payment formula uses the Average Manufacturer Price of drugs rather than the previously used Average Wholesale Price. Although the rule was published as final, CMS is soliciting additional comments

WASHINGTON — Retail pharmacy associations spoke out last week opposing the “final” Medicaid generic drug reimbursement formula, released on July 6 by the Centers for Medicare & Medicaid Services, Baltimore.

The new payment formula uses the Average Manufacturer Price of drugs rather than the previously used Average Wholesale Price. Although the rule was published as final, CMS is soliciting additional comments on the definition of AMP.

The new formula will reimburse

Register to view the full article